Sep 2026· Khyber Journal of Medical Sciences· Vol 19· 0 citations· 23 references
TL;DR
Post-treatment symptom scores were lower than baseline scores; however, the uncontrolled design, study-specific non-validated outcome measure, and incompletely specified treatment protocol preclude conclusions regarding efficacy or routine clinical use.
Abstract
Objective: To assess the change in clinical symptom scores and describe adverse effects following amphotericin B nasal irrigation in adults with chronic rhinosinusitis with nasal polyps.
Methods: This single-group pretest-posttest quasi-experimental study was conducted in the Department of Otorhinolaryngology, Lady Reading Hospital, Peshawar, from 24 July 2025 to 24 January 2026. Eighty-nine consecutively recruited adults with complete paired records were assessed using a study-specific four-item symptom score. Normality was evaluated with the Shapiro-Wilk test. Because paired score differences were non-normally distributed, pre-treatment and post-treatment scores were compared using two-sided Wilcoxon signed-rank tests.
Results: The median age was 41 years (interquartile range [IQR], 36-46), and 46 (51.69%) participants were men. The median total symptom score decreased from 10 (IQR, 9-10) before treatment to 5 (IQR, 5-6) after treatment, with a median paired reduction of 5 points (IQR, 4-5; p<0.001). All four symptom components also showed lower post-treatment scores (all p<0.001). Minor local adverse effects were recorded in 51 (57.30%) participants: mild irritation in 24 (26.97%), mild dryness in 14 (15.73%), and burning sensation in 13 (14.61%). No serious adverse effect was recorded.
Conclusions: Post-treatment symptom scores were lower than baseline scores; however, the uncontrolled design, study-specific non-validated outcome measure, and incompletely specified treatment protocol preclude conclusions regarding efficacy or routine clinical use.
Objectives: Budesonide irrigation (BI) has emerged as an effective postoperative topical therapy for chronic rhinosinusitis (CRS), providing improved drug delivery compared with conventional intranasal corticosteroid sprays. However, evidence regarding its role as a maintenance strategy during the critical postoperativ...
S. T. Kim, Jin-Young Min· Journal of Clinical Medicine· 0 citations
OBJECTIVE
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, effectively reduced polyp size in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Tezepelumab also reduced the need for nasal polyp surgery and systemic corticosteroids (SCS) in the phase 3 WAYPOINT study across 10 countri...
N. Otori, Daiju Sakurai, Genki Iwai et al.· Auris, nasus, larynx· 0 citations
To evaluate the efficacy and safety of adjunctive shoseiryuto, a traditional Japanese Kampo medicine, in patients with refractory eosinophilic chronic rhinosinusitis (ECRS), with particular attention to mucus‐related symptoms.
This retrospective pilot case series was conducted at Osaka Medical and Pharmace...
Yusuke Kikuoka· Traditional & Kampo Medi...· 0 citations
Preliminary findings support the potential role of the saccharin test as a simple, objective tool for monitoring response to biologic therapy and support the potential role of the saccharin test as a simple, objective tool for monitoring response to biologic therapy.
G. Pagliuca, Veronica Clemenzi, S. Martellucci et al.· European archives of oto-rhi...· 0 citations
The observed trend toward enhanced benefit in T2-high patients supports the potential for endotype-directed therapy and underscores the need for larger studies to evaluate the role of T2-targeted biologics in CRSsNP management.
J. Tversky, Andrew P. Lane, John T. Schroeder et al.· Journal of Allergy and Clini...· 0 citations
Background/Objectives: Dupilumab blocks the interleukin-4 receptor alpha (IL-4Rα) subunit, thereby inhibiting IL-4- and IL-13-mediated signaling, and is an effective treatment for severe chronic rhinosinusitis with nasal polyps (CRSwNP). This study assessed clinical response and histopathological changes reflecting eos...
B. Kamiński, Dominika Ochab, Janusz Kopczyński et al.· Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.